Icatibant Glenmark
Icatibant Glenmark is a medicine used to treat symptoms of hereditary angioedema (HAE) in adults, adolescents, and children aged 2 years and older by blocking the effect of bradykinin.
Form
injektioneste, liuos, esitäytetty ruisku
Strength
30 mg
Active Ingredient
Icatibant acetate
Manufacturer
Glenmark Arzneimittel GmbH
How to Use
Dosage
Adults receive one injection (3 ml, 30 mg) and children (2-17 years) receive a weight-based dose (1-3 ml, 10-30 mg) as soon as an HAE attack starts.
Method
The medicine is given as an injection under the skin into the fatty tissue of the abdomen. Each pre-filled syringe is for single use only.
Important
No more than 3 injections within 24 hours. If you need more than 8 injections in a month, talk to your doctor.
Possible Side Effects
COMMON
- •Injection site reactions (e.g., feeling of pressure, bruising, reduced sensation, numbness, raised itchy rash, feeling of warmth)
- •Nausea
- •Headache
- •Dizziness
- •Fever
- •Itching
- •Rash
- •Skin redness
- •Abnormal liver function test
RARE
- •Hives
Important Warnings
- Do not use if you are allergic to icatibant or any other ingredients of this medicine.
- Talk to your doctor if you have angina (chest pain from reduced blood flow to the heart) or have recently had a stroke.
- Tell your doctor immediately if your attack symptoms worsen after receiving this medicine.
- If you have an attack involving swelling in the larynx (airway blockage), seek immediate medical attention.
- If you are pregnant, breastfeeding, or planning to become pregnant, ask your doctor for advice. Do not breastfeed for 12 hours after taking this medicine.
Show 1 more warnings
- Do not drive or operate machinery if you feel tired or dizzy after an HAE attack or after using this medicine.